title: Neuroendocrine carcinoma of the head and neck: a 20-year case series.
abstract: Neuroendocrine carcinoma (NEC) can be an aggressive disease with locoregional and distant metastasis. We present this article (1) to highlight the typical presentation of NEC in head and neck primary sites such as the parotid gland, paranasal sinuses, and supraglottis and (2) to discuss the prognosis of these tumors based on their histologic subtype and stage. We base our comments on the findings of our retrospective review of the cases of 16 adults-10 men and 6 women, aged 43 to 88 years (mean: 65.8)-who had been diagnosed with pathologically confirmed NEC of the head and neck. Analysis of subtypes revealed that 11 of these patients (68.8%) had presented with poorly differentiated NEC, 4 (25.0%) with moderately differentiated NEC, and 1 (6.3%) with well-differentiated NEC. The most common primary sites were the salivary glands (n = 5; 31.3%), paranasal sinuses (n = 4, 25.0%), and larynx (n = 4). There was no statistically significant difference in survival at 24 months between the patients with moderately differentiated NEC and those with poorly differentiated NEC (37.5 vs. 35.4%; p = 0.86); at the end of the study period, the patient with well-differentiated NEC was still living, 129 months after diagnosis. Taken together, patients with stage I, II, and III disease had a combined survival of 77.8% at 12 months, which was significantly higher (p = 0.023) than the 57.1% survival at 12 months for patients with stage IV disease.
authors.affiliation: Department of Otolaryngology, University of Tennessee Health Science Center, Memphis, TN, USA. ryanmeacham@gmail.com
authors.forename: Ryan
authors.initials: R
authors.lastname: Meacham
authors.forename: Laura
authors.initials: L
authors.lastname: Matrka
authors.forename: Enver
authors.initials: E
authors.lastname: Ozer
authors.forename: H Gulcin
authors.initials: HG
authors.lastname: Ozer
authors.forename: Paul
authors.initials: P
authors.lastname: Wakely
authors.forename: Manisha
authors.initials: M
authors.lastname: Shah
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D018278:Carcinoma, Neuroendocrine / Q000473:pathology* / Q000628:therapy; D005260:Female; D006801:Humans; D053208:Kaplan-Meier Estimate; D007822:Laryngeal Neoplasms / Q000473:pathology* / Q000628:therapy; D008297:Male; D008875:Middle Aged; D010255:Paranasal Sinus Neoplasms / Q000473:pathology* / Q000628:therapy; D012468:Salivary Gland Neoplasms / Q000473:pathology* / Q000628:therapy